More than half of payers, 58%, had at least one outcomes-based contract (OBC) in place during the 2022 plan year, and respondents to a new Avalere survey who are utilizing at least one OBC indicated oncology, cardiology, and endocrinology as the top therapeutic areas in which OBCs came into play last year.

Skip to content